Science37 aims to democratize clinical research with a fresh $29 million in growth funding

Virtual clinical trials have come into their own thanks to widespread technology enabling patients of every background to input their experiences at the tap of a button. Science37 capitalizes on that trendby providing qualified patients free tools to participate from the comfort of their own home and the company has just raised $29 million in Series C funding to help it reach new audiences. Read More
Click here to read full news..